| Autor: |
Rosenthal J; Department of Radiology and Imaging Sciences, Section of Musculoskeletal Imaging, Emory University Hospital, 59 Executive Park South, 4th Floor, Suite 4009, Atlanta, GA, 30329, USA., Cardona K; Department of Surgical Oncology, Emory University Hospital, Atlanta, GA, USA., Sayyid SK; Department of Radiology and Imaging Sciences, Section of Musculoskeletal Imaging, Emory University Hospital, 59 Executive Park South, 4th Floor, Suite 4009, Atlanta, GA, 30329, USA., Perricone AJ; Department of Pathology, Emory University Hospital, Atlanta, GA, USA., Reimer N; Department of Orthopedic Surgery, Emory University Hospital, Atlanta, GA, USA., Monson D; Department of Orthopedic Surgery, Emory University Hospital, Atlanta, GA, USA., Singer AD; Department of Radiology and Imaging Sciences, Section of Musculoskeletal Imaging, Emory University Hospital, 59 Executive Park South, 4th Floor, Suite 4009, Atlanta, GA, 30329, USA. adamsinger82@gmail.com. |
| Abstrakt: |
Soft tissue sarcomas (STS) are malignancies derived from connective tissue, and regional lymph node metastasis (RLNM), while not common, is an important aspect of prognosis and treatment. Various risk factors, in particular the histological subtype, affect the likelihood of nodal involvement, which can be characterized by imaging features such as nodal dimension and morphology. Currently, surveillance and management vary by institution, as concrete societal guidelines have not been established. Common nodal status assessment strategies include physical exam, US CT, MRI, sentinel lymph node biopsy (SLNB) and radical lymphadenectomy. This article summarizes data regarding relevant risk factors of RLNM, imaging features, and any available data regarding surveillance recommendations. |
Full text from SpringerLink